Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2s,3s)-3-((5-fluoro-2-(5-fluoro-1h-pyrrolo(2,3-b)pyridin-3-yl)-4-pyrimidinyl)amino)bicyclo(2.2.2)octane-2-carboxylic Acid
2. Bicyclo(2.2.2)octane-2-carboxylic Acid, 3-((5-fluoro-2-(5-fluoro-1h-pyrrolo(2,3-b)pyridin-3-yl)-4-pyrimidinyl)amino)-, (2s,3s)-
3. Jnj-63623872
4. Vx-787
1. 1629869-44-8
2. Vx-787
3. Pimodivir [usan]
4. Jnj872
5. Jnj-63623872
6. Vx-787 Anhydrous Base
7. Jnj-63623872-zcd
8. Jnj63623872
9. Dfc121mxc3
10. Chembl3318007
11. Jnj-872
12. (2s,3s)-3-((5-fluoro-2-(5-fluoro-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)bicyclo[2.2.2]octane-2-carboxylic Acid
13. (2s,3s)-3-[[5-fluoranyl-2-(5-fluoranyl-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic Acid
14. Bicyclo(2.2.2)octane-2-carboxylic Acid, 3-((5-fluoro-2-(5-fluoro-1h-pyrrolo(2,3-b)pyridin-3-yl)-4-pyrimidinyl)amino)-, (2s,3s)-
15. (2s,3s)-3-[[5-fluoro-2-(5-fluoro-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic Acid
16. 21g
17. Pimodivir(vx-787
18. 4p1u
19. Pimodivir [inn]
20. Pimodivir (usan/inn)
21. Pimodivir (vx-787)
22. Unii-dfc121mxc3
23. Pimodivir [who-dd]
24. Schembl2128140
25. Schembl16728380
26. Schembl20150447
27. Dtxsid801028095
28. Ex-a1387
29. Bdbm50050712
30. Hy-12353a
31. Zinc98208077
32. At13207
33. Cs-6423
34. Db14974
35. Vx -787
36. Ncgc00510523-01
37. Ac-30922
38. Jnj - 63623872 - Zcd
39. D11287
40. Q27276370
41. (1r,2s,3s,4r)-3-{[5-fluoro-2-(5-fluoro-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino}bicyclo[2.2.2]octane-2-carboxylic Acid
42. (2s,3s)-3-((5-fluoro-2-(5-fluoro-1h-pyrrolo(2,3-b)pyridin- 3-yl)pyrimidin-4-yl)amino)bicyclo(2.2.2)octane-2-carboxylic Acid
43. (2s,3s)-3-(5-fluoro-2-(5-fluoro-1h-pyrrolo(2,3-b)pyridin-3-yl)pyrimidin-4-ylamino)bicyclo(2.2.2)octane-2-carboxylic Acid
44. 1259366-34-1
45. 3-[[5-fluoro-2-(5-fluoro-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic Acid; Vx787; (2s,3s)-3-((5-fluoro-2-(5-fluoro-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)bicyclo[2.2.2]octane-2-carboxylic Acid
Molecular Weight | 399.4 g/mol |
---|---|
Molecular Formula | C20H19F2N5O2 |
XLogP3 | 3.8 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 4 |
Exact Mass | 399.15068119 g/mol |
Monoisotopic Mass | 399.15068119 g/mol |
Topological Polar Surface Area | 104 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 620 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of influenza
ABOUT THIS PAGE
A Pimodivir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pimodivir, including repackagers and relabelers. The FDA regulates Pimodivir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pimodivir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pimodivir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pimodivir supplier is an individual or a company that provides Pimodivir active pharmaceutical ingredient (API) or Pimodivir finished formulations upon request. The Pimodivir suppliers may include Pimodivir API manufacturers, exporters, distributors and traders.
click here to find a list of Pimodivir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Pimodivir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pimodivir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pimodivir GMP manufacturer or Pimodivir GMP API supplier for your needs.
A Pimodivir CoA (Certificate of Analysis) is a formal document that attests to Pimodivir's compliance with Pimodivir specifications and serves as a tool for batch-level quality control.
Pimodivir CoA mostly includes findings from lab analyses of a specific batch. For each Pimodivir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pimodivir may be tested according to a variety of international standards, such as European Pharmacopoeia (Pimodivir EP), Pimodivir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pimodivir USP).
LOOKING FOR A SUPPLIER?